ZNF33B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.364260E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.894800E-01
Normal-vs-Stage2
8.047700E-04
Normal-vs-Stage3
7.218900E-03
Normal-vs-Stage4
3.144600E-01
Stage1-vs-Stage2
3.224400E-01
Stage1-vs-Stage3
2.243800E-02
Stage1-vs-Stage4
5.601000E-01
Stage2-vs-Stage3
1.004350E-01
Stage2-vs-Stage4
8.364400E-01
Stage3-vs-Stage4
1.131370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.215640E-03
Normal-vs-AfricanAmerican
8.382000E-02
Normal-vs-Asian
1.183200E-01
Caucasian-vs-AfricanAmerican
8.851400E-01
Caucasian-vs-Asian
4.145200E-01
AfricanAmerican-vs-Asian
6.225800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.255240E-03
Normal-vs-Female
1.699410E-01
Male-vs-Female
2.887000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.561600E-02
Normal-vs-Age(41-60Yrs)
8.595900E-04
Normal-vs-Age(61-80Yrs)
3.583600E-04
Normal-vs-Age(81-100Yrs)
1.503650E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.702600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.620600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.968800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.158200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.211400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.702800E-01
Normal-vs-Daily Drinker
8.196300E-02
Normal-vs-Weekly Drinker
1.757670E-02
Normal-vs-Occasional Drinker
1.588150E-01
Normal-vs-Social Drinker
1.066850E-01
Non Drinker-vs-Daily Drinker
9.102000E-01
Non Drinker-vs-Weekly Drinker
3.401600E-01
Non Drinker-vs-Occasional Drinker
7.963400E-01
Non Drinker-vs-Social Drinker
5.134000E-01
Daily Drinker-vs-Weekly Drinker
4.330600E-01
Daily Drinker-vs-Occasional Drinker
8.960200E-01
Daily Drinker-vs-Social Drinker
5.403000E-01
Weekly Drinker-vs-Occasional Drinker
3.850800E-01
Weekly Drinker-vs-Social Drinker
7.142400E-01
Occasional Drinker-vs-Social Drinker
4.767400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.639500E-02
Normal-vs-Grade 2
1.436320E-02
Normal-vs-Grade 3
2.730400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.243200E-01
Grade 1-vs-Grade 3
8.190200E-01
Grade 1-vs-Grade 4
4.639500E-02
Grade 2-vs-Grade 3
2.776600E-01
Grade 2-vs-Grade 4
1.436320E-02
Grade 3-vs-Grade 4
2.730400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.209500E-04
Normal-vs-NonDiabetic
7.990600E-04
Diabetic-vs-NonDiabetic
4.267000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.848100E-02
Normal-vs-NoPancreatitis
7.159600E-04
Pancreatitis-vs-NoPancreatitis
7.392400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.378370E-03
Normal-vs-N1
5.626500E-04
N0-vs-N1
7.126800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.607200E-01
Normal-vs-TP53-NonMutant
8.215400E-01
TP53-Mutant-vs-TP53-NonMutant
4.625000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
